We have listed in section 1.48 the weaknesses that were identified. I believe that list was sufficient as an analysis of the types of gaps in their information collection. Some of them are fairly significant, showing that they do not have that broad source of information about antimicrobial use and resistance.
On April 29th, 2015. See this statement in context.